Negri F; Musolino A; Naldi N; Bortesi B; Boni C; Bisagni G; Camisa R; Ardizzoni A, Immunoglobulin g fragment c receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with Cetuximab-based therapy, «ANNALS OF ONCOLOGY», 2007, 18, pp. 10 - 10 [abstract]
Musolino A; Naldi N; Bortesi B; Capelletti M; Pezzuolo D; Michiara M; Missale G; Laccabue D; Zerbini A; Camisa R; Ardizzoni A, Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer, «BREAST CANCER RESEARCH AND TREATMENT», 2007, 103, pp. 119 - 120 [abstract]
Musolino A; Guazzi A; Lazzaretti M; Pezzuolo D; Calzetti C; Degli Antoni A; Ardizzoni A, Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia., «HAEMATOLOGIA», 2007, 92, pp. 59 - 61 [replica/breve intervento]
Eckardt JR; von Pawel J; Pujol JL; Papai Z; Quoix E; Ardizzoni A; Poulin R; Preston AJ; Dane G; Ross G, Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2007, 25, pp. 2086 - 2092 [replica/breve intervento]
BOZZETTI C; NIZZOLI R; MUSOLINO A; MARTELLA EM; CRAFA P; LAGRASTA CA; CAMISA R; BONATI A; LUNGHI P; ARDIZZONI A, P73 and p53 pathway in human breast cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2007, 25, pp. 1451 - 1453 [replica/breve intervento]
Tiseo M; Martelli O; Mancuso A; Sormani MP; Bruzzi P; Di Salvia R; De Marinis F; Ardizzoni A, Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma, «TUMORI», 2007, 93, pp. 138 - 144 [replica/breve intervento]
Tiseo M; Boni C; Baldini E; Boni L; Recchia F; Barone C; Manzione L; Grossi F; Matano E; Zanelli F; Prochilo T; Ardizzoni A, Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV nonsmall cell lung cancer (NSCLC) patients: Preliminary results of a multicenter randomized factorial study, «ANNALS OF ONCOLOGY», 2007, 18, pp. 36 - 36 [abstract]
Boni L; Sormani MP; Bruzzi P; Tiseo M; Rosell R; Ardizzoni A, Tumor response to chemotherapy as a surrogate endpoint of survival in advanced non-small cell lung cancer (NSCLC): Results of an individual patients data meta-analysis, «ANNALS OF ONCOLOGY», 2007, 18, pp. 24 - 24 [abstract]
Tiseo M; Franciosi V; Grossi F; Ardizzoni A, Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?, «EUROPEAN JOURNAL OF CANCER», 2006, 42, pp. 8 - 16 [replica/breve intervento]
Ardizzoni A; Tiseo M; Boni L; Rosell R; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella A; Mazzanti P; Bisset D, CISCA (cisplatin vs. carboplatin) meta-analysis: An individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC)., «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. 366S - 366S [abstract]
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M, Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer, «CANCER», 2006, 107, pp. 2842 - 2849 [replica/breve intervento]
Bozzetti C; Musolino A; Camisa R; Bisagni G; Flora M; Bassano C; Martella E; Lagrasta C; Nizzoli R; Personeni N; Leonardi F; Cocconi G; Ardizzoni A, Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer - The role of anthrocycline dose intensity, «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2006, 29, pp. 171 - 177 [replica/breve intervento]
Scartozzi M; Franciosi V; Campanini N; Benedetti G; Barbieri F; Rossi G; Berardi R; Camisa R; Silva RR; Santineelli A; Ardizzoni A; Crino L; Rindi G; Cascinu S, Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients, «LUNG CANCER», 2006, 53, pp. 103 - 109 [replica/breve intervento]
Tiseo M; Franciosi V; Ardizzoni A, Multi-target inhibitors in non-small cell lung cancer (NSCLC), «ANNALS OF ONCOLOGY», 2006, 17, pp. 55 - 57 [replica/breve intervento]
Ardizzoni A; Tiseo M, Novel targeted approaches in non-small cell lung cancer (NSCLC), «ANNALS OF ONCOLOGY», 2006, 17, pp. V91 - V93 [replica/breve intervento]
